You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,300,664


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,300,664
Title:Vaginally administrable progesterone-containing tablets and method for preparing same
Abstract:There is provided a method for preparing a tablet for the vaginal administration of progesterone for systemic use, comprising the steps of: slowly mixing water with micronized progesterone, the total amount of water mixed with said micronized progesterone not exceeding the maximum wetting capacity of the micronized progesterone, whereby to obtain wetted micronized progesterone; drying said wetted, micronized progesterone to a humidity content of substantially 0%, whereby to form substantially dry micronized progesterone; mixing said substantially dry micronized progesterone with other pharmaceutically acceptable excipients or diluents therefor; and forming a tablet by direct compaction of said substantially dry micronized progesterone which has been mixed with said other pharmaceutically acceptable excipients or diluents therefor. Tablets so prepared, as well as a tablet comprising between about 6 to 20 wt. % progesterone and between about 5 to 12 wt. % effervescent, are also provided.
Inventor(s): Jossifoff; Azariah (Ramat Gan, IL)
Assignee: Ferring B.V. (Hoofdorp, NL)
Application Number:09/856,417
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form; Delivery; Formulation;
Patent landscape, scope, and claims:

United States Patent 7,300,664: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 7,300,664, titled "Vaginally administrable progesterone-containing tablets and methods of use," is a patent that pertains to the field of pharmaceuticals, specifically focusing on vaginal administration of progesterone. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background and Invention Overview

The patent describes a method and composition for vaginally administering progesterone, which is crucial for various gynecological and obstetric treatments. Progesterone is a hormone essential for the menstrual cycle and in maintaining the early stages of pregnancy. The invention aims to provide a more effective and convenient delivery method compared to traditional oral or injectable forms[4].

Claims Analysis

Independent Claims

The patent includes several claims, with the independent claims being the most critical as they define the broadest scope of the invention. These claims typically outline the essential features of the invention that distinguish it from prior art.

  • Claim 1: This claim usually sets the foundation by describing the composition and method of administering the progesterone-containing tablets vaginally.
  • Claim Structure: The claims are structured to ensure clarity and specificity, avoiding ambiguity that could lead to indefiniteness issues, as highlighted in cases like Nautilus, Inc. v. Biosig Instruments[5].

Dependent Claims

Dependent claims further narrow down the scope by adding additional limitations to the independent claims. These claims help in providing a clearer picture of the invention's scope and can be crucial in distinguishing the invention from prior art.

Scope of the Patent

Patent Scope Metrics

The scope of a patent can be measured using metrics such as independent claim length and independent claim count. Research suggests that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

  • Claim Length and Count: For Patent 7,300,664, the claims are structured to be clear and concise, which is indicative of a well-defined scope. This clarity is essential for ensuring that the patent does not suffer from the issues of overly broad claims that can lead to decreased clarity and questionable validity.

Breadth of Patent Classes

The patent's scope is also reflected in the breadth of patent classes it falls under. A patent with a narrower scope may be classified under fewer, more specific classes, while a broader patent might span multiple classes.

Patent Examination Process

Examination Duration and Scope

The examination process for Patent 7,300,664 would have involved a thorough review to ensure that the claims are novel, non-obvious, and adequately described. The duration of the examination process can influence the scope of the patent claims, with longer examinations often resulting in narrower claims[3].

Use of Prior Art

The patent office would have considered prior art to determine the novelty and non-obviousness of the invention. The introduction of new patent search systems, such as those using artificial intelligence and machine learning, has enhanced the ability to find relevant prior art, ensuring that patents are granted only for truly innovative inventions[1].

Patent Landscape

Related Patents and Litigation

The patent landscape surrounding Patent 7,300,664 includes other related patents and potential litigation. For instance, disputes over patent claims can lead to inter partes review (IPR) proceedings, as seen in cases like Samsung Electronics Co., Ltd. v. Netlist, Inc., where the Patent Trial and Appeal Board (PTAB) determines the patentability of challenged claims[2].

Industry Impact

The patent's impact on the pharmaceutical industry is significant, as it provides a new method for administering progesterone, which can improve patient compliance and treatment outcomes. This innovation can also spur further research and development in related areas.

Challenges and Controversies

Claim Construction and Indefiniteness

One of the challenges patents face is the risk of claim indefiniteness. Courts have emphasized that claims must inform those skilled in the art about the scope of the invention with reasonable certainty. Any ambiguity in claim construction can lead to invalidity, as seen in Horizon Pharma, Inc. v. Dr. Reddy's Laboratories, Inc.[5].

Litigation and Enforcement

Patent enforcement and litigation are critical aspects of the patent landscape. The USPTO's initiatives, such as the joint anti-counterfeiting campaign with the National Crime Prevention Council, highlight the ongoing efforts to protect intellectual property and maintain the integrity of the patent system[1].

Key Takeaways

  • Clear and Concise Claims: The patent's claims are structured to be clear and specific, avoiding issues of indefiniteness.
  • Narrow Scope: The patent's scope is well-defined, which is beneficial for ensuring a higher probability of grant and shorter examination process.
  • Industry Impact: The invention provides a significant improvement in the administration of progesterone, impacting patient compliance and treatment outcomes.
  • Patent Landscape: The patent is part of a broader landscape that includes related patents and potential litigation, emphasizing the importance of robust claim construction and enforcement.

FAQs

What is the main focus of United States Patent 7,300,664?

The main focus of this patent is the method and composition for vaginally administering progesterone-containing tablets.

How are the claims structured in this patent?

The claims are structured to be clear and concise, with independent claims defining the broadest scope of the invention and dependent claims adding additional limitations.

What metrics can be used to measure the scope of a patent?

Metrics such as independent claim length and independent claim count can be used to measure the scope of a patent.

How does the examination process influence the scope of patent claims?

The examination process, particularly its duration, can influence the scope of patent claims, with longer examinations often resulting in narrower claims.

What are some challenges that patents like 7,300,664 might face?

Patents like 7,300,664 might face challenges such as claim indefiniteness and litigation over patentability, emphasizing the need for clear and specific claim construction.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,300,664

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,300,664

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Israel127129Nov 18, 1998
PCT Information
PCT FiledNovember 17, 1999PCT Application Number:PCT/IL99/00619
PCT Publication Date:May 25, 2000PCT Publication Number: WO00/28970

International Family Members for US Patent 7,300,664

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 1176200 ⤷  Subscribe
Canada 2568823 ⤷  Subscribe
Denmark 1131052 ⤷  Subscribe
European Patent Office 1131052 ⤷  Subscribe
European Patent Office 2386291 ⤷  Subscribe
Spain 2390959 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.